1-9 of 9
Stephen Palmer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Estimating Long-Term Survival in a Cohort of Allogeneic Hematopoietic Stem Cell Transplant Patients

Stephen Palmer, MSc, Casey Quinn, PhD MPhil, Crystal Watson, MS, Arie Barlev, PharmD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3556.
https://doi.org/10.1182/blood-2018-99-113616
Published: 2018
Journal Articles

Mir-15a/16-1 Haploinsufficiency Contributes To Myeloma Progression

Marta Chesi, PhD, Victoria Garbitt, Stephen Palmer, P. Leif Bergsagel, MD
Journal: Blood
Blood (2013) 122 (21): 1850.
https://doi.org/10.1182/blood.V122.21.1850.1850
Published: 2013
Journal Articles

IAP Antagonists Are a Novel Class Of Immunomodulators That Induce Complete Response In Vk*MYC Myeloma By Stimulating Plasmacytoid Dendritic Cells To Secrete IFNa

Marta Chesi, PhD, Victoria Garbitt, Stephen Palmer, P. Leif Bergsagel, MD
Journal: Blood
Blood (2013) 122 (21): 128.
https://doi.org/10.1182/blood.V122.21.128.128
Published: 2013
Journal Articles

Dysregulation Of Cyclin D1 Or Activation Of KRAS Accelerate The Development Of Monoclonal Gammopathy and Cooperate To Cause Its Progression

Marta Chesi, PhD, Victoria Garbitt, Stephen Palmer, P. Leif Bergsagel, MD
Journal: Blood
Blood (2013) 122 (21): 3103.
https://doi.org/10.1182/blood.V122.21.3103.3103
Published: 2013
Journal Articles

Genome Wide Studies in Multiple Myeloma Identify XPO1/CRM-1 As a Critical Target Validated Using the Selective Inhibitor of Nuclear Export (SINE) KPT-276

Jessica Schmidt, Esteban Braggio, Ph.D., Marta Chesi, PhD, Jan Egan, PhD, Yuan Xiao Zhu, PhD, Chang-Xin Shi, PhD, Stephen Palmer, Victoria Garbitt, Dilara McCauley, PhD, Sharon Shacham, PhD MBA, Michael Kauffman, MD, PhD, Leif Bergsagel, MD, Keith Stewart, MD
Journal: Blood
Blood (2012) 120 (21): 573.
https://doi.org/10.1182/blood.V120.21.573.573
Published: 2012
Journal Articles

The Vk*MYC Mouse Model of Myeloma Identifies Successful Combination Therapies for the Treatment of Bortezomib Refractory Myeloma Patients

Marta Chesi, Stephen Palmer, Victoria Garbitt, P. Leif Bergsagel
Journal: Blood
Blood (2010) 116 (21): 3015.
https://doi.org/10.1182/blood.V116.21.3015.3015
Published: 2010
Journal Articles

The Vk*MYC Mouse Model of Myeloma Accurately Reflects Clinical Efficacy of Established and Novel Drugs.

Marta Chesi, PhD, Stephen Palmer, Peter Leif Bergsagel, Comprehensive Cancer Center, Mayo Clinic, Scottsdale, AZ, USA
Journal: Blood
Blood (2009) 114 (22): 1849.
https://doi.org/10.1182/blood.V114.22.1849.1849
Published: 2009
Journal Articles

A Novel Transgenic Mouse Model of Multiple Myeloma Reliably Predicts Drug Response.

Michael Sebag, MD, PhD, Keith Stewart, MBCHB, Stephen Palmer, BSc, Richard Kremer, MD PhD, Peter Leif Bergsagel, MD, Marta Chesi, PhD
Journal: Blood
Blood (2006) 108 (11): 241.
https://doi.org/10.1182/blood.V108.11.241.241
Published: 2006
Journal Articles

Chemical Library Screening Identifies Novel Inhibitors of Cyclin D2 ( CCND2) Transactivation That Selectively Induce Apoptosis in Multiple Myeloma Cells.

Rodger E. Tiedemann, MD, PhD, Xinliang Mao, PhD, Chng-Xin Shi, PhD, Yuan Xiao Zhang, PhD, Stephen Palmer, Craig B. Reeder, MD, Aaron Schimmer, MD, Keith Stewart, MD
Journal: Blood
Blood (2006) 108 (11): 3421.
https://doi.org/10.1182/blood.V108.11.3421.3421
Published: 2006